Legal Representation
Attorney
S. Peter Ludwig
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 25, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 25, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 20, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 18, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 18, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 18, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 11, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 11, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 30, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 26, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 26, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 26, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 21, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 27, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 27, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 7, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 15, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 8, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 3, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 1, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical devices for endovascular occlusion, treatment of vascular abnormalities, and for embolization, namely, endovascular including devices that conform to vessel walls and promote clot formation in neurovascular and peripheral vascular structures, medical devices for treatment of aneurysms and vascular disease and for peripheral vascular embolization
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"NEUROVASCULAR SYSTEM"